Inhalation Sciences installs first DissolvIt[®][ ]module at Swiss-based laboratory of global corporation
Inhalation Sciences (ISAB) has successfully installed its first ever commercial version of the in vitro DissolvIt[®] module at the Swiss laboratory of a long-term ISAB customer. The module was the first of three shipments that were announced and sent to customers in March just before strict Covid-19 restrictions came into force in many countries worldwide. CEO Manoush Masarrat: “We aim to hit the ground running now that laboratory restrictions in many locations are easing”.From its commercial launch in spring 2020, demand for DissolvIt[®] has been strong. Three modules were shipped to three